波士顿科学公司的收入超过第二季度预期, 报告收入增长20.9%,达到46亿美元. Boston Scientific beats Q2 earnings expectations, reporting a 20.9% rise in revenue to $4.66 billion.

波士顿科学公司报告Q2收入强劲,每股0.75美元,超过分析师的预期,收入增长20.9%,达到46.6亿美元。 Boston Scientific Corporation reported strong Q2 earnings of $0.75 per share, exceeding analyst expectations and showing a 20.9% revenue increase to $4.66 billion. 皇家财富集团有限公司最近向该公司投资214 000美元,收购了2 126股股票。 Crown Wealth Group LLC recently invested $214,000 in the company, acquiring 2,126 shares. 该公司的市场上限为158.05亿美元,“Buy”评级为116.09美元,目标价格为116.09美元。 The firm's market cap stands at $158.05 billion, with a "Buy" rating and a target price of $116.09. 尽管有内部销售,波士顿科学公司在医疗设备部门保持强劲的财政前景。 Despite insider sales, Boston Scientific maintains a strong financial outlook in the medical equipment sector.